Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | GRO-a | 3314.0 | 41 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | GRO-a | 4917.5 | 52 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | GRO-a | 13393.0 | 43 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | GRO-a | 16955.0 | 43 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | GRO-a | 17435.0 | 37 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | GRO-a | 18668.0 | 45 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | GRO-a | 935.0 | 34 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | GRO-a | 21273.0 | 33 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | GRO-a | 19948.0 | 56 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | GRO-a | 46.0 | 45 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | GRO-a | 41.0 | 37 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | GRO-a | 720.0 | 55 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | GRO-a | 1469.0 | 47 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | GRO-a | 136.0 | 46 | ||||
RA1931 | IKK16 | 2.0 | uM | 1 | GRO-a | 143.0 | 39 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | GRO-a | 436.0 | 50 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | GRO-a | 248.0 | 52 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | GRO-a | 47.0 | 37 | ||||
RA1869 | 1 | GRO-a | 43.0 | 44 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | GRO-a | 2095.5 | 44 | ||||
N2759 | 1 | GRO-a | 1710.0 | 33 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | GRO-a | 303.0 | 36 | ||||
RA1931 | 1 | GRO-a | 58.0 | 32 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 1 | GRO-a | 1118.0 | 26 | ||||
N2586 | 1 | GRO-a | 547.5 | 44 |